Cleared Traditional

K212720 - nordicDSC

K212720 is the FDA 510(k) clearance for nordicDSC by Nordicneurolab AS. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 188-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2022
Decision
188d
Days
Class 2
Risk

K212720 is an FDA 510(k) clearance for the nordicDSC. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Nordicneurolab AS (Bergen, NO). The FDA issued a Cleared decision on March 3, 2022 after a review of 188 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Nordicneurolab AS devices

Submission Details

510(k) Number K212720 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 27, 2021
Decision Date March 03, 2022
Days to Decision 188 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
81d slower than avg
Panel avg: 107d · This submission: 188d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1090
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K212720.
ClariPulmo
K203783 · Claripi, Inc. · Apr 2022
DTX Studio Clinic 3.0
K213562 · Nobel Biocare AB · Mar 2022
RI.HIP MODELER
K212040 · Blue Belt Technologies, Inc. · Mar 2022
EzOrtho v1.3
K220003 · Ewoosoft Co., Ltd. · Feb 2022
Rapid
K213165 · Ischemaview, Inc. · Feb 2022
Veuron-Brain-pAb2
K213801 · Heuron Co., Ltd. · Feb 2022